Optimal Pharmacological Therapy In Implantable Defibrillator Patients (OPTIC)
Information source: Connolly, Stuart, M.D.
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Ventricular Tachycardia
Intervention: amiodarone beta blocker sotalol (Drug)
Phase: Phase 4
Status: Completed
Sponsored by: Connolly, Stuart, M.D. Official(s) and/or principal investigator(s):
Stuart Connolly, Principal Investigator, Affiliation: Hamilton Health Sciences
Stuart Connolly, Principal Investigator, Affiliation: Hamilton Health Sciences
Summary
This is an open parallel design randomized trial of amiodarone plus a beta blocker vs a beta
blocker alone vs sotalol for the prevention of ICD shocks in patients receiving an ICD for
spontaneous or inducible ventricular tachycardia or fibrillation
Clinical Details
Study design: Prevention, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Primary outcome: ICD shock for any cause
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria: spontaneous or inducible ventricular tachycardia or fibrillation -
Exclusion Criteria:
-
Locations and Contacts
McMaster University, Hamilton, Ontario, Canada
Additional Information
Starting date: January 2001
Ending date: October 2004
Last updated: July 26, 2006
|
